ГЕМОКОАГУЛЯЦИОННЫЕ СДВИГИ ПРИ ЛУЧЕВОЙ ТЕРАПИИ РАКА ШЕЙКИ МАТКИ И СИСТЕМНОЙ ЭНЗИМОТЕРАПИИ
2012 год | Выпуск: 5 | Страницы: 128-129
НЕКОТОРЫЕ ИЗМЕНЕНИЯ СИСТЕМЫ ИММУНИТЕТА ПРИ СПЕЦИФИЧЕСКОЙ ТЕРАПИИ РАКА ЯИЧНИКОВ
| Выпуск: 5 | Страницы: 126-127
ЭФФЕКТИВНОСТЬ БИСФОСФОНАТОВ ПРИ МНОЖЕСТВЕННЫХ КОСТНЫХ МЕТАСТАЗАХ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
2012 год | Выпуск: 5 | Страницы: 125-126
РЕЗУЛЬТАТЫ ЛУЧЕВОЙ ТЕРАПИИ РАКА ЛЕГКИХ И ПРИМЕНЕНИЯ ПРЕДУКТАЛА
2012 год | Выпуск: 5 | Страницы: 124-125
ТКАНЕВЫЕ ФАКТОРЫ ИММУНИТЕТА ПРИ ДОБРОКАЧЕСТВЕННЫХ ОПУХОЛЯХ ТЕЛА МАТКИ
2012 год | Выпуск: 5 | Страницы: 123-124
ҚАЗАҚСТАНДАҒЫ ӘЙЕЛДЕР АРАСЫНДА ТҮСІК ЖАСАТУ ТӘЖІРИБЕСІ: КӨЛДЕНЕҢ ЗЕРТТЕУ
2024 год | Выпуск: 2 | Страницы: 76-81
ШАЛА ТУЫЛҒАН НӘРЕСТЕЛЕРДЕГІ ГЕМОДИНАМИКАЛЫҚ МАҢЫЗДЫ ПАТЕНТТЕЛГЕН АРТЕРИЯЛЫҚ ТҮТІК. ӘДЕБИ ШОЛУ
2024 год | Выпуск: 2 | Страницы: 171-183
ШЫҒЫС ҚАЗАҚСТАН ОБЛЫСЫНЫҢ ТҰРҒЫНДАРЫНДА СҮТ БЕЗІ ҚАТЕРЛІ ІСІГІН СКРИНИНГТЕН ӨТУГЕ КЕДЕРГІЛЕР
2024 год | Выпуск: 2 | Страницы: 68-75
РАДИОЙОДҚА ТӨЗІМДІ ҚАЛҚАНША БЕЗІНІҢ САРАЛАНҒАН ОБЫРЫ: КЛИНИКО-ПАТОЛОГИЯЛЫҚ СИПАТТАМАЛАРЫ, МОЛЕКУЛЯРЛЫҚ-ГЕНЕТИКАЛЫҚ АЛЬТЕРАЦИЯЛАРЫ. ӘДЕБИ ШОЛУ.
2024 год | Выпуск: 2 | Страницы: 158-170
ЖҰЛЫННЫҢ ЗАҚЫМДАНУЫ БАР АДАМДАРДА НЕВРОГЕНДІК ҚУЫҚТЫ ЕМДЕУДІҢ «АЛТЫН СТАНДАРТЫ» РЕТІНДЕ ҚУЫҚТЫҢ АРАЛЫҚ КАТЕТЕРИЗАЦИЯСЫ
2024 год | Выпуск: 2 | Страницы: 148-157
CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM
Calcium channels blockers – group of the drugs which basic property is ability to brake a calcium current inside of smooth muscle cells through the special channels named “slow calcium channels”. Diltiazem Lannacher renders cardioprotective action with antioxidative effect, angioprotective action, antiagregant action, antiatherogenous action, nephroprotective action, cerebroprotective action.
Подробнее
2012 год | Выпуск: 2 | Страницы: 24-34
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN
Arterial hypertension (AH) is independent risk factor of myocardial infarction, brain stroke, chronic heart failure (CHF) and hypertensive nephropathy, death from cardiovascular diseases.
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
Подробнее
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
Подробнее
2012 год | Выпуск: 2 | Страницы: 18-24
ORGANIZATION OF CARE FOR THE PEOPLE AT MGA "MSU FOR ELDERLY AND GENERAL TYPE WITH DISABLED" SEMEY SITI
In connection with the sudden changes in the demographic structure of the society, it will be actual to implement the nursing process in different health institutions of the Republic of Kazakhstan. The main purpose of this research was a creation of ways for optimization of care model for residents of "Health care establishment for elderly and disabled persons of general type" of the Semey city on the basis of the complex examination results. The project has been carried out through the work of the scientific and practical Nursing School.
Подробнее
2012 год | Выпуск: 2 | Страницы: 15-17
THE ROLE OF A DOCTOR IN THE RELATIONSHIPS WITH PATIENTS
In order to implement the basic principles of a healthcare reform to achieve quality and efficiency of medical care provided to patients is necessary to ensure the unity of the doctor and the patient. These theoretical principles could be realized by the creation of «Schools of Health».
Подробнее
2012 год | Выпуск: 2 | Страницы: 13-15
ORGANIZATIONAL AND METHODOLOGICAL ASPECTS OF CARDIOVASCULAR MORTALITY RATE REGISTRATION
This article describes the results of the study on cardiovascular mortality rate in primary care. More than 80% of the pop-ulation dies from cardiovascular disease in the lack of medical care. The problems an accurate statement of cardiovascular mortality rate registration and solutions are given.
Подробнее
2012 год | Выпуск: 2 | Страницы: 10-12